Doximity price target raised to $75 from $52 at Barclays

Barclays raised the firm’s price target on Doximity (DOCS) to $75 from $52 and keeps an Overweight rating on the shares. The company reported a strong fiscal Q2 that continued the recent beat/raise trend, with positive data points across end market demand, user engagement, and early self service portal traction, the analyst tells investors in a research note.